| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
First Department of Pathology, Hiroshima University School of Medicine, 1-2-3 Kasumi, Minami-ku, Hiroshima 734, Japan
The effect of transforming growth factor ß (TGF-ß) on human gastric carcinoma cell lines was examined. Cell growth and DNA synthesis of TMK-1 were inhibited by TGF-ß, whereas MKN-28 presented no response to TGF-ß. Scatchard plot analysis of TGF-ß binding showed that TMK-1 had a relatively small number of high-affinity receptors, whereas MKN-28 had a large number of low-affinity receptors. By affinity labeling, only the type I receptor (Mr 65,000) for TGF-ß was detected in TMK-1, while three types of receptors, type I, type II (Mr 85,00095,000), and type III (Mr 250,000350,000), for TGF-ß were present in MKN-28. TGF-ß treatment reduced p34cdc-2 kinase activity and the level of phosphorylation of retinoblastoma protein in TMK-1, whereas it did not affect them in MKN-28. mRNAs for MYC and platelet-derived growth factor B chain were increased by treatment of TGF-ß on TMK-1. cAMP-responsive element binding activity was decreased by TGF-ß treatment in MKN-28 but not in TMK-1. This was closely correlated with protein kinase C activity.
These results suggest that the type I receptor for TGF-ß in human gastric carcinoma cells may be mainly linked with the growth inhibition of TGF-ß by a decrease in retinoblastoma protein phosphorylation by p34cdc-2 without suppression of MYC expression. Conversely, TGF-ß may reduce protein kinase C activity and cAMP-responsive element binding activity in TGF-ß-resistant gastric carcinoma cells.
1 Supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Health and Welfare for a Comprehensive 10-Year Strategy for Cancer Control and from the Ministry of Education, Science and Culture, Japan.
2 To whom requests for reprints should be addressed.
Received 7/ 8/91. Accepted 11/13/91.
This article has been cited by other articles:
![]() |
M. L. G. Lamm, D. D. Long, S. M. Goodwin, and C. Lee Transforming Growth Factor-{beta}1 Inhibits Membrane Association of Protein Kinase C{alpha} in a Human Prostate Cancer Cell Line, PC3 Endocrinology, November 1, 1997; 138(11): 4657 - 4664. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Ward, A. Agrotis, P. Kanellakis, R. Dilley, G. Jennings, and A. Bobik Inhibition of Protein Tyrosine Kinases Attenuates Increases in Expression of Transforming Growth Factor-ß Isoforms and Their Receptors Following Arterial Injury Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2461 - 2470. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |